Begin main content

Patient Input and Clinical Experts: Duobrii

Published on: December 19, 2019
Result type: News

CADTH has received the following notice(s) of pending drug submission(s).

Brand name Halobetasol propionate and tazarotene
Generic name Duobrii
Manufacturer Bausch Health, Canada Inc.
Indication(s) Psoriasis, moderate to severe plaque
Project Number SR0638-000
Call for patient input 2019-12-19
Patient input deadline 2020-02-14
Submit patient input Submit
Register as Clinical Expert Register